- Home
- CGON vs NUV Comparison
CGON vs NUV Comparison
Compare CGON & NUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- NUV
- Stock Information
- Founded
- CGON 2010
- NUV 1987
- Country
- CGON United States
- NUV United States
- Employees
- CGON N/A
- NUV N/A
- Industry
- CGON
- NUV Trusts Except Educational Religious and Charitable
- Sector
- CGON
- NUV Finance
- Exchange
- CGON NYSE
- NUV Nasdaq
- Market Cap
- CGON 2.1B
- NUV 1.8B
- IPO Year
- CGON 2024
- NUV N/A
- Fundamental
- Price
- CGON $25.55
- NUV $8.53
- Analyst Decision
- CGON Strong Buy
- NUV
- Analyst Count
- CGON 10
- NUV 0
- Target Price
- CGON $64.44
- NUV N/A
- AVG Volume (30 Days)
- CGON 784.3K
- NUV 464.9K
- Earning Date
- CGON 08-07-2025
- NUV 01-01-0001
- Dividend Yield
- CGON N/A
- NUV 3.96%
- EPS Growth
- CGON N/A
- NUV N/A
- EPS
- CGON N/A
- NUV N/A
- Revenue
- CGON $662,000.00
- NUV N/A
- Revenue This Year
- CGON N/A
- NUV N/A
- Revenue Next Year
- CGON $14,719.70
- NUV N/A
- P/E Ratio
- CGON N/A
- NUV N/A
- Revenue Growth
- CGON 224.51
- NUV N/A
- 52 Week Low
- CGON $14.80
- NUV $7.86
- 52 Week High
- CGON $40.47
- NUV $9.08
- Technical
- Relative Strength Index (RSI)
- CGON 48.31
- NUV 45.95
- Support Level
- CGON $25.02
- NUV $8.43
- Resistance Level
- CGON $26.97
- NUV $8.62
- Average True Range (ATR)
- CGON 1.14
- NUV 0.06
- MACD
- CGON -0.18
- NUV 0.00
- Stochastic Oscillator
- CGON 17.79
- NUV 50.00
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About NUV Nuveen Municipal Value Fund Inc.
Nuveen Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories.